Cointime

Coral Genomics

company

About

Coral develops new clinical tests to help providers streamline prior authorization and select the effective medication.

  • 1 - 10

Highlights

Total Funding Amount
$3.70M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.70M
Industries
Biotechnology,Genetics,Health Care
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Coral develops new clinical tests to help providers streamline prior authorization and select the effective medication for a particular patient focusing on autoimmune conditions such as Inflammatory Bowel Disease and Rheumatoid Arthritis. It has also identified a unique population of non-responder patients and is working with drug developers to address this unmet medical need.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$3.70M
Coral Genomics has raised a total of $3.70M in funding over 2 rounds. Their latest funding was raised on Jan 28, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 28, 2021 Grant $1.70M 1 National Institutes of Health — Detail
Oct 6, 2020 Grant $2M 1 National Human Genome Research Institute — Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Coral Genomics is funded by 2 investors. National Institutes of Health and National Human Genome Research Institute are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
National Human Genome Research Institute Yes Grant
Cointime
Content
Company